ArticleJournal of gynecologic oncology2025

Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.

Amy Jamieson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.